Text Size

DBT in Borderline Personality Disorder

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2005 by Bronx VA Medical Center.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Bronx VA Medical Center
ClinicalTrials.gov Identifier:
NCT00252031
First received: November 9, 2005
Last updated: November 17, 2005
Last verified: November 2005
History of Changes
  Purpose

Subjects will receive a 6-month course of DBT, consisting of one 90-minute group and one 60-minute individual session per week as well as telephone availability of the individual therapist.


Condition Intervention
Borderline Personality Disorder
 Behavioral: Dialectical Behavioral Therapy

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Dialectical Behavioral Therapy for Patients With Borderline Personality Disorder

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Bronx VA Medical Center:

Primary Outcome Measures:
  • Measures of parasuicidal behavior, suicidal ideation, mood and emotion, dissociation and health care utilization at baseline, 3 months, 6 months and 9 months

Secondary Outcome Measures:
  • Measures of cognitive processing at baseline and 6 months

  Eligibility

Ages Eligible for Study:   18 Years to 60 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria: Is a male or female between 18 and 60 who meets criteria for Borderline Personality Disorder and has had at least 2 prior instances of suicidal or parasuicidal behavior. Either is off psychotropic drugs or is on a stable medication regimen. (During the study, psychotropic medications will be prescribed by a psychiatrist in the Mood and Personality Disorders Group.)

Exclusion Criteria: Meets criteria for Schizophrenia, Bipolar Disorder, Mental Retardation or current or recent Substance Dependence. Subjects also should not currently be in individual psychotherapy. (Case management and work therapy programs are allowed.)

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00252031

Contacts
Contact: Emily Hart 212-241-0441 mpgroup@mssm.edu

Locations
United States, New York
Bronx VA Medical Center Recruiting
Bronx, New York, United States, 10468
Sponsors and Collaborators
Bronx VA Medical Center
Investigators
Principal Investigator: Marianne Goodman, MD Bronx VA Medical Center/Mount Sinai School of Medicine
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00252031     History of Changes
Other Study ID Numbers: 3277-02-0002
Study First Received: November 9, 2005
Last Updated: November 17, 2005
Health Authority: United States: Federal Government

Keywords provided by Bronx VA Medical Center:
Borderline Personality Disorder
BPD
Dialectical Behavior Therapy
DBT

Additional relevant MeSH terms:
Personality Disorders
Borderline Personality Disorder
Mental Disorders

ClinicalTrials.gov processed this record on May 23, 2013